comparemela.com

Latest Breaking News On - Multi drug resistant - Page 8 : comparemela.com

United BioPharma gets FDA approval for phase 2 HIV drug trial

United BioPharma says the FDA has approved a clinical trial IND submitted by the U.S. National Institute of Allergy and Infectious Diseases. 

NIAID/NIH recognizes the potency of UB-421 against multi-drug resistant HIV and receives the FDA approval to conduct a phase 2 clinical trial with UB-421

/PRNewswire/ United BioPharma (UBP) announced today that the U.S. Food and Drug Administration (FDA) has approved a phase 2 clinical trial IND submitted by.

vimarsana © 2020. All Rights Reserved.